{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:13:49Z","timestamp":1778148829164,"version":"3.51.4"},"reference-count":10,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"abstract":"<jats:p>There are significant knowledge gaps regarding the burden and clinical progression of ocular manifestations of mpox in Nigeria and worldwide. Here, we report two laboratory-confirmed mpox cases in young male adults with different presentations of ocular mpox at two tertiary hospitals in southern Nigeria during the 2022\/2024 global outbreak. The first patient, a 28-year-old man, presented at the Alex Ekwueme Federal University Teaching Hospital in Abakaliki with a vesiculopustular rash on his nasal bridge and right lower eyelid, along with redness, pain, and itching. He later developed corneal ulcers and vision problems during follow-up after discharge. The second case involved a 44-year-old man with advanced, treatment-naive HIV infection. He presented with widespread vesiculo-pustular skin eruptions, including characteristic rashes around the periorbital and orbital areas. His condition rapidly worsened, leading to his death after seven days of hospitalisation. Consistent with guidance from the Nigeria Center for Disease Control and Prevention, lesional skin swabs from both patients were sent to the National Reference Laboratory in Abuja for quantitative polymerase chain reaction (qPCR), which tested positive for the monkeypox virus. Supportive care included antibiotics, fluids, nutritional support, and skin care, as no specific mpox treatments were available at that time. A multidisciplinary team, without an ophthalmologist, managed the care. Ocular mpox has been increasingly reported since the 2022 global outbreak. Continued surveillance and research are vital for monitoring mpox's evolving epidemiology, understanding eye-related diseases and potential complications, and improving prevention and treatment strategies for both systemic and ocular symptoms to prevent severe vision loss and enhance overall patient outcomes.<\/jats:p>","DOI":"10.11604\/pamj.2026.53.162.48485","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:55:24Z","timestamp":1778147724000},"source":"Crossref","is-referenced-by-count":0,"title":["Ocular mpox in Southern Nigeria during the 2022\/2024 outbreak: a report of two cases"],"prefix":"10.11604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-1927","authenticated-orcid":false,"given":"Chizaram Anselm","family":"Onyeaghala","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4814-8384","authenticated-orcid":false,"given":"Nneka Marian","family":"Chika-Igwenyi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4870","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019 Oct;13(10):e000779. PubMed | Google Scholar","DOI":"10.1371\/journal.pntd.0007791"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Begley J, Kaftan T, Song H, Fashina T, Hartley CD, Nguyen N et al. Ocular Complications of Mpox: Evolving Understanding and Future Directions. International Ophthalmology Clinics. 2024 Fall;64(4):15. PubMed | Google Scholar","DOI":"10.1097\/IIO.0000000000000536"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Miura F, van Ewijk CE, Backer JA, Xiridou M, Franz E, Op de Coul E et al. Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022. Euro Surveill. 2022 Jun;27(24):2200448. PubMed | Google Scholar","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Mmerem JI, Umenzekwe CC, Johnson SM, Onukak AE, Chika-Igwenyi NM, Chukwu SK et al. Mpox and Chickenpox Coinfection: Case Series From Southern Nigeria. J Infect Dis. 2024 Mar 26;229(Supplement_2):S260-. PubMed | Google Scholar","DOI":"10.1093\/infdis\/jiad556"},{"key":"ref4","unstructured":"Mitj\u00e0 O, Alemany A, Marks M, Mora JIL, Rodr\u00edguez-Aldama JC, Silva MST et al. Mpox in people with advanced HIV infection: a global case series. The Lancet. 2023 Mar 18;401(10380):939-49. PubMed | Google Scholar"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ogoina D, Iroezindu M, James HI, Oladokun R, Yinka-Ogunleye A, Wakama P et al. Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin Infect Dis. 2020 Nov 5;71(8):e210-4. PubMed | Google Scholar","DOI":"10.1093\/cid\/ciaa143"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Hughes C, McCollum A, Pukuta E, Karhemere S, Nguete B, Lushima RS et al. Ocular complications associated with acute monkeypox virus infection, DRC. International Journal of Infectious Diseases. 2014 Apr 1;21:276-7. Google Scholar","DOI":"10.1016\/j.ijid.2014.03.994"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bragazzi NL, Kong JD, Mahroum N, Tsigalou C, Khamisy-Farah R, Converti M, Wu J. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review. J Med Virol. 2023 Jan;95(1):e27931. PubMed | Google Scholar","DOI":"10.1002\/jmv.27931"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bhamray-Sanchez D, Subramanian S, Dever LL, Chew D. Ocular MPox: A report of two cases. IDCases. 2023;31:e01706. PubMed | Google Scholar","DOI":"10.1016\/j.idcr.2023.e01706"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Reynolds MG, McCollum AM, Nguete B, Shongo Lushima R, Petersen BW. Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research. Viruses. 2017; 9(12):380. PubMed | Google Schola","DOI":"10.3390\/v9120380"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:55:33Z","timestamp":1778147733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/53\/162\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":10,"URL":"https:\/\/doi.org\/10.11604\/pamj.2026.53.162.48485","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"48485"}}